Literature DB >> 12130936

Antibiotic policies and control of resistance.

Ian M Gould1.   

Abstract

PURPOSE OF THE REVIEW: The current worldwide pandemic of antibiotic resistance shows no signs of abating. It is clear that it is driven mainly by heavy and often inappropriate antibiotic use. Although control measures are widely practised, it is important that we assess their efficacy critically in order to concentrate expensive control efforts where they will be most effective. The past year has seen much activity in this area, with evidence-based assessments of the literature according to strict guidelines, as well as progress in basic science studies of mechanisms of resistance, and their causes and relations to pathogenicity and adaptability. RECENT
FINDINGS: The present review summarizes current developments in the causes of antibiotic resistance, the classification of antibiotic stewardship and control measures, the evidence base for their efficacy, current problems in hospital practice, the adaptability of bacteria, the content of antibiotic policies and anticipated activities.
SUMMARY: The conclusions from the published literature are that much of it that pertains to changing prescribing practices does not stand up to modern evidence-based analysis concepts. Nevertheless, we can learn from experience in changing other areas of medical practice. We must be pragmatic and must not expect to change the world, but rather take it step by step, recognizing barriers and measuring outcomes and quality indicators. Studies into the molecular basis of resistance confirm the superb genetic adaptability of micro-organisms. They will always be several steps ahead of us. Nevertheless, we are learning how to modify our prescribing habits to minimize resistance, not only by using antibiotics less frequently but also by altering dosing schedules in various ways.

Mesh:

Substances:

Year:  2002        PMID: 12130936     DOI: 10.1097/00001432-200208000-00007

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  14 in total

1.  Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans.

Authors:  D Andes; A Forrest; A Lepak; J Nett; K Marchillo; L Lincoln
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

2.  Real-time quantitative broad-range PCR assay for detection of the 16S rRNA gene followed by sequencing for species identification.

Authors:  Franziska Zucol; Roland A Ammann; Christoph Berger; Christoph Aebi; Martin Altwegg; Felix K Niggli; David Nadal
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  Relationship of antimicrobial control policies and hospital and infection control characteristics to antimicrobial resistance rates.

Authors:  Elaine L Larson; Dave Quiros; Tara Giblin; Susan Lin
Journal:  Am J Crit Care       Date:  2007-03       Impact factor: 2.228

4.  The impact of an intensive antimicrobial control program in a Taiwanese medical center.

Authors:  Ming-Tsung Chang; Tzu-Hua Wu; Chun-Yu Wang; Tsrang-Neng Jang; Chien-Yu Huang
Journal:  Pharm World Sci       Date:  2006-10-26

Review 5.  Multidisciplinary Treatment Approach for Prosthetic Vascular Graft Infection in the Thoracic Aortic Area.

Authors:  Takeshiro Fujii; Yoshinori Watanabe
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-09-08       Impact factor: 1.520

6.  Otitis Media: A Review, with a Focus on Alternative Treatments.

Authors:  L M T Dicks; H Knoetze; C A van Reenen
Journal:  Probiotics Antimicrob Proteins       Date:  2009-03-04       Impact factor: 5.265

7.  Antimicrobial Use and Resistance.

Authors:  Michael A. Rubin; Matthew H. Samore
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.663

8.  Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study.

Authors:  Julian Mettler; Mathew Simcock; Pedram Sendi; Andreas F Widmer; Roland Bingisser; Manuel Battegay; Ursula Fluckiger; Stefano Bassetti
Journal:  BMC Infect Dis       Date:  2007-03-26       Impact factor: 3.090

9.  Analysis of known bacterial protein vaccine antigens reveals biased physical properties and amino acid composition.

Authors:  Carl Mayers; Melanie Duffield; Sonya Rowe; Julie Miller; Bryan Lingard; Sarah Hayward; Richard W Titball
Journal:  Comp Funct Genomics       Date:  2003

10.  Outcome measurement of extensive implementation of antimicrobial stewardship in patients receiving intravenous antibiotics in a Japanese university hospital.

Authors:  T Niwa; Y Shinoda; A Suzuki; T Ohmori; M Yasuda; H Ohta; A Fukao; K Kitaichi; K Matsuura; T Sugiyama; N Murakami; Y Itoh
Journal:  Int J Clin Pract       Date:  2012-07-31       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.